Search Results
3101 - 3105 of 3105
| Title | Wire | Date | Time |
|---|---|---|---|
| Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL | Globe Newswire | 07/10 | 09:30 |
| RENEW Energy Partners Upgrades Mass General Brigham’s Energy Portfolio to Unlock Capital | Globe Newswire | 07/09 | 08:00 |
| Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance | Globe Newswire | 07/07 | 19:30 |
| First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy | Globe Newswire | 07/07 | 03:00 |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CTO Realty Growth, Inc. - CTO | Globe Newswire | 07/06 | 10:00 |
3101 - 3105 of 3105
